1st RNA meeting Mendelian diseases
Sep 05, 2023
The first RNA meeting about Mendelian disease starts tomorrow, September 6th, 2023.
The complete scientific program down below.
8:30 – 8:45 Welcome – Auricchio and Brunetti (TIGEM)
Control of gene expression in Mendelian diseases (Session Chair: Nicola Brunetti)
8:45 – 9:15 Sandro Banfi (TIGEM): “Modulation of microRNA expression: a new therapeutic avenue for inherited retinal disease”
9:15 – 9:45 Alessia Indrieri (TIGEM-IRGB): “Modulation of miR-181a/b as gene-independent therapeutic tool for mitochondrial diseases”
9:45 – 10:15 Elisabetta Tabolacci (UniCatt Rome): “Role of DNMT1 in the epigenetic regulation of the FMR1 gene”
10:15 – 10:45 Coffee break
Novel nucleic acid therapeutics 1 (Session Chair: Alberto Auricchio)
10:45 – 11:15 Gian Gaetano Tartaglia (IIT-Genoa): “Prediction of protein-RNA interactions and applications in neurodegeneration”
11:15 – 11:45 Paloma Giangrande (Wave Therapeutics): “RNA base editing”
11:45 – 12:15 Angela Gallo (IRCCS Bambino Gesù) “Epitranscriptomic crosstalks and cancer cell-killing alternatives”
12:15 – 13:45 LUNCH BREAK
Novel nucleic acid therapeutics 2 (Session Chair: V de Franciscis, Alessia Indrieri)
13:45 – 14:45 Stefano Gustincich (IIT-Genoa) Keynote: “RNA therapeutics for precise targeting”
14:45 – 15:15 Annalisa Di Ruscio (Harvard Medical School): “The hidden avenue of RNA therapeutics in DNA methylation”
15:15 – 15:45 Coffee break
15:45 – 16:15 Velia Siciliano (IIT-Naples): “Regulatory tools for RNA-encoded genetic circuits”
Therapeutic Delivery (Session Chair: Angela Gallo)
16:15 – 16:45 Jeanne Leblond Chain (INSERM Bordeaux) “Aptamer assemblies fortargeting and delivery”
16:45 – 17:15 Pasquale Piccolo (TIGEM): “miRNA-based therapy for liver fibrosis”
17:15 - 17:45 Daniele Catalucci (IRGB): “Inhalable calcium phosphate nanoparticles for the treatment of heart diseases”
17:45 – 18:00 General Discussion and Concluding Remarks Brunetti, Indrieri and V de Franciscis
The complete scientific program down below.
SCIENTIFIC PROGRAM
8:30 – 8:45 Welcome – Auricchio and Brunetti (TIGEM)
Control of gene expression in Mendelian diseases (Session Chair: Nicola Brunetti)
8:45 – 9:15 Sandro Banfi (TIGEM): “Modulation of microRNA expression: a new therapeutic avenue for inherited retinal disease”
9:15 – 9:45 Alessia Indrieri (TIGEM-IRGB): “Modulation of miR-181a/b as gene-independent therapeutic tool for mitochondrial diseases”
9:45 – 10:15 Elisabetta Tabolacci (UniCatt Rome): “Role of DNMT1 in the epigenetic regulation of the FMR1 gene”
10:15 – 10:45 Coffee break
Novel nucleic acid therapeutics 1 (Session Chair: Alberto Auricchio)
10:45 – 11:15 Gian Gaetano Tartaglia (IIT-Genoa): “Prediction of protein-RNA interactions and applications in neurodegeneration”
11:15 – 11:45 Paloma Giangrande (Wave Therapeutics): “RNA base editing”
11:45 – 12:15 Angela Gallo (IRCCS Bambino Gesù) “Epitranscriptomic crosstalks and cancer cell-killing alternatives”
12:15 – 13:45 LUNCH BREAK
Novel nucleic acid therapeutics 2 (Session Chair: V de Franciscis, Alessia Indrieri)
13:45 – 14:45 Stefano Gustincich (IIT-Genoa) Keynote: “RNA therapeutics for precise targeting”
14:45 – 15:15 Annalisa Di Ruscio (Harvard Medical School): “The hidden avenue of RNA therapeutics in DNA methylation”
15:15 – 15:45 Coffee break
15:45 – 16:15 Velia Siciliano (IIT-Naples): “Regulatory tools for RNA-encoded genetic circuits”
Therapeutic Delivery (Session Chair: Angela Gallo)
16:15 – 16:45 Jeanne Leblond Chain (INSERM Bordeaux) “Aptamer assemblies fortargeting and delivery”
16:45 – 17:15 Pasquale Piccolo (TIGEM): “miRNA-based therapy for liver fibrosis”
17:15 - 17:45 Daniele Catalucci (IRGB): “Inhalable calcium phosphate nanoparticles for the treatment of heart diseases”
17:45 – 18:00 General Discussion and Concluding Remarks Brunetti, Indrieri and V de Franciscis